Your browser doesn't support javascript.
loading
Plasmodium 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration-Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials.
Chavtur, Chris; Staubus, Weston J; Ho, Mabel; Hergott, Dianna E B; Seilie, Annette M; Healy, Sara; Duffy, Patrick; Jackson, Lisa; Talley, Angela; Kappe, Stefan H I; Hoffman, Stephen L; Richie, Thomas L; Kublin, James G; Chang, Ming; Murphy, Sean C.
Afiliação
  • Chavtur C; Malaria Molecular Diagnostic Laboratory, Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Staubus WJ; Malaria Molecular Diagnostic Laboratory, Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Ho M; Malaria Molecular Diagnostic Laboratory, Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Hergott DEB; Malaria Molecular Diagnostic Laboratory, Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Seilie AM; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
  • Healy S; Malaria Molecular Diagnostic Laboratory, Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Duffy P; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Jackson L; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • Talley A; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
  • Kappe SHI; Spero Therapeutics, Cambridge, Massachusetts, USA.
  • Hoffman SL; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Richie TL; Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Kublin JG; Sanaria, Rockville, Maryland, United States.
  • Chang M; Sanaria, Rockville, Maryland, United States.
  • Murphy SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Open Forum Infect Dis ; 10(5): ofad202, 2023 May.
Article em En | MEDLINE | ID: mdl-37265668
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article